Jane Street’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.67M | Sell |
63,300
-98,600
| -61% | -$15.1M | ﹤0.01% | 2581 |
|
|
2025
Q4 | $22.3M | Buy |
161,900
+142,500
| +735% | +$18.7M | ﹤0.01% | 1524 |
|
|
2025
Q3 | $2.49M | Sell |
19,400
-13,200
| -40% | -$1.61M | ﹤0.01% | 4532 |
|
|
2025
Q2 | $3.94M | Sell |
32,600
-242,800
| -88% | -$27.4M | ﹤0.01% | 3342 |
|
|
2025
Q1 | $30.7M | Buy |
275,400
+264,100
| +2,337% | +$28.1M | 0.01% | 977 |
|
|
2024
Q4 | $1.1M | Buy |
+11,300
| New | +$1.21M | ﹤0.01% | 5199 |
|
|
2024
Q3 | – | Sell |
-105,600
| Closed | -$11.2M | – | 10148 |
|
|
2024
Q2 | $11.2M | Buy |
+105,600
| New | +$10.6M | ﹤0.01% | 1908 |
|
|
2024
Q1 | – | Sell |
-103,100
| Closed | -$10.4M | – | 9810 |
|
|
2023
Q4 | $10.4M | Sell |
103,100
-38,800
| -27% | -$3.75M | ﹤0.01% | 1905 |
|
|
2023
Q3 | $14.5M | Sell |
141,900
-800
| -0.6% | -$81.2K | ﹤0.01% | 1393 |
|
|
2023
Q2 | $14.4M | Sell |
142,700
-23,700
| -14% | -$2.37M | ﹤0.01% | 1528 |
|
|
2023
Q1 | $15.3M | Sell |
166,400
-80,600
| -33% | -$7.04M | 0.01% | 1215 |
|
|
2022
Q4 | $22.4M | Buy |
247,000
+120,900
| +96% | +$10.2M | 0.01% | 923 |
|
|
2022
Q3 | $9.59M | Sell |
126,100
-13,000
| -9% | -$1.08M | ﹤0.01% | 1739 |
|
|
2022
Q2 | $11.8M | Sell |
139,100
-48,000
| -26% | -$4.21M | 0.01% | 1563 |
|
|
2022
Q1 | $16.4M | Buy |
187,100
+16,100
| +9% | +$1.39M | 0.01% | 1454 |
|
|
2021
Q4 | $15M | Sell |
171,000
-89,800
| -34% | -$7.46M | ﹤0.01% | 1445 |
|
|
2021
Q3 | $21.3M | Buy |
260,800
+84,600
| +48% | +$7.61M | 0.01% | 1098 |
|
|
2021
Q2 | $16.1M | Sell |
176,200
-96,300
| -35% | -$8.58M | 0.01% | 1266 |
|
|
2021
Q1 | $23.3M | Sell |
272,500
-38,400
| -12% | -$3.45M | 0.01% | 867 |
|
|
2020
Q4 | $29.4M | Buy |
310,900
+89,100
| +40% | +$7.79M | 0.01% | 660 |
|
|
2020
Q3 | $19.3M | Buy |
221,800
+75,600
| +52% | +$6.55M | 0.01% | 793 |
|
|
2020
Q2 | $12.8M | Buy |
146,200
+51,900
| +55% | +$4.48M | 0.01% | 1025 |
|
|
2020
Q1 | $7.78M | Buy |
94,300
+28,700
| +44% | +$2.56M | 0.01% | 920 |
|
|
2019
Q4 | $6.21M | Buy |
65,600
+24,700
| +60% | +$2.22M | 0.01% | 916 |
|
|
2019
Q3 | $3.55M | Buy |
40,900
+21,400
| +110% | +$1.92M | 0.01% | 1255 |
|
|
2019
Q2 | $1.78M | Sell |
19,500
-10,744
| -36% | -$909K | ﹤0.01% | 2008 |
|
|
2019
Q1 | $2.6M | Buy |
30,244
+23,548
| +352% | +$1.89M | ﹤0.01% | 1740 |
|
|
2018
Q4 | $515K | Sell |
6,696
-21,539
| -76% | -$1.68M | ﹤0.01% | 3423 |
|
|
2018
Q3 | $2.18M | Buy |
28,235
+21,427
| +315% | +$1.58M | ﹤0.01% | 1806 |
|
|
2018
Q2 | $461K | Sell |
6,808
-1,004
| -13% | -$69.3K | ﹤0.01% | 3662 |
|
|
2018
Q1 | $566K | Buy |
+7,812
| New | +$595K | ﹤0.01% | 3352 |
|
|
2017
Q4 | – | Sell |
-8,593
| Closed | -$661K | – | 4999 |
|
|
2017
Q3 | $661K | Buy |
8,593
+5,022
| +141% | +$379K | ﹤0.01% | 2778 |
|
|
2017
Q2 | $267K | Buy |
3,571
+446
| +14% | +$31.6K | ﹤0.01% | 3717 |
|
|
2017
Q1 | $208K | Sell |
3,125
-3,125
| -50% | -$208K | ﹤0.01% | 3833 |
|
|
2016
Q4 | $408K | Buy |
6,250
+1,228
| +24% | +$79.7K | ﹤0.01% | 3058 |
|
|
2016
Q3 | $355K | Sell |
5,022
-2,567
| -34% | -$187K | ﹤0.01% | 3128 |
|
|
2016
Q2 | $561K | Sell |
7,589
-1,785
| -19% | -$123K | ﹤0.01% | 2647 |
|
|
2016
Q1 | $608K | Buy |
9,374
+5,022
| +115% | +$342K | ﹤0.01% | 2398 |
|
|
2015
Q4 | $336K | Buy |
+4,352
| New | +$346K | ﹤0.01% | 2954 |
|
|
2013
Q3 | – | Sell |
-19,976
| Closed | -$1.27M | – | 2991 |
|
|
2013
Q2 | $1.27M | Buy |
+19,976
| New | +$1.3M | 0.02% | 725 |
|
Other funds holding NVS
Jane Street's NVS Position: Q1 2026 in Review
Jane Street opened a new position in Novartis (NVS) in Q1 2026: 366,467 shares worth $56M. The stake represents 0.01% of the portfolio and ranks #979 among its holdings. This is a return to the name: Jane Street previously reported a position in NVS as recently as Q3 2025.
Jane Street first reported a position in NVS in Q2 2013 and has held it in 48 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Jane Street held 366,467 shares of Novartis worth $56M as of Q1 2026.
- Novartis was a new Jane Street position in Q1 2026.
- Novartis made up 0.01% of Jane Street's portfolio in Q1 2026, its #979 holding.
- Jane Street first reported a position in Novartis in Q2 2013 and has held it in 48 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.